Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Marksans Pharma

BSE: 524404|NSE: MARKSANS|ISIN: INE750C01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 14, 16:00
35.35
-0.8 (-2.21%)
VOLUME 539,002
LIVE
NSE
Dec 14, 15:59
35.20
-0.9 (-2.49%)
VOLUME 5,729,751
Announcements on Marksans Pharma

13th-Nov-2017 13:03Source: NSE

Marksans Pharma Limited

Marksans Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.

13th-Nov-2017 12:51Source: BSE

Marksans Pharma- Updates

News Release dated 13.11.2017

13th-Nov-2017 12:48Source: BSE

Marksans Pharma- Unaudited Financial Result As On 30.09.2017

Unaudited Financial Result as on 30.09.2017

2nd-Nov-2017 15:59Source: BSE

Marksans Pharma- Board Meeting On 13.11.2017

This is to inform you that the Meeting of the Board of Directors of the Company will be held on Monday, 13th November, 2017 at Mumbai, to consider and approve the Unaudited Financial Results of the Co...

2nd-Nov-2017 15:47Source: BSE

Marksans Pharma- Closure of Trading Window

This is to inform you that the Meeting of the Board of Directors of the Company will be held on Monday, 13th November, 2017 at Mumbai, to consider and approve the Unaudited Financial Results of the Co...

26th-Oct-2017 14:56Source: BSE

Marksans Pharma- Reg. 40(9) Of SEBI(LODR)Regulations, 2015 For The Half Year Ended 30.09.2017.

Reg. 40(9) of SEBI(LODR)Regulations, 2015 for the half year ended 30.09.2017.

17th-Oct-2017 17:20Source: BSE

Marksans Pharma- Shareholding for the Period Ended September 30, 2017

Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

16th-Oct-2017 13:47Source: BSE

Marksans Pharma- Compliance Certificate For The Period 30Th September, 2017

Compliance Certificate for the period 30th September, 2017

11th-Oct-2017 17:57Source: BSE

Marksans Pharma- Statement Of Investor Complaints For The Quarter Ended 30Th September, 2017 Under Regulation 13(3) Of SEBI (LODR), 2015.

Pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below a statement of Investor complaints for the quarter ended 30th September, 201...

9th-Oct-2017 14:48Source: BSE

Marksans Pharma- Updates

Receipt of Establishments Inspection Report (EIR)from the US FDA

1 2 3 4 5 Next >>
Quick Links for Marksans Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.